未登録の方はこちらから登録できます。
TEL．03-5812-5270
FAX．03-3831-0495
E-mail：info@spi-information.com
市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。
当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。
Comparison of Pharma Outsourcing between China and India
中国とインドにおける医薬アウトソーシングの比較
周知のように、世界の製薬業界は、現在、数々の課題に直面しています。この業界で経験している困難は、すべての製薬企業に現在の経営モデルの変更を強いています。R&Dや製造において、業務をより効率よく、費用対効果が高く、かつ生産的な方法を追求することが余儀なくされています。その鍵となるのは、迅速に薬剤を発見し、迅速に開発し、安く製造し、かつ広く販売することです。
アウトソーシングは、製薬企業にとって効率的なソリューションの1つとして実証されています。アウトソーシングのすべての新興国において、中国とインドは、低価格と品質サービスのユニークな組み合わせを有する国として、世界の医薬品アウトソーシングにおいて急浮上しました。大幅なコスト削減を求めている多くの製薬企業にとって、これらの2国の重要性は高まっています。
しかし、中国とインドは、製薬関連産業だけではなく、社会構造のほぼすべての側面において、独特の機能や特徴をもっています。中国やインドにおいてアウトソーシングを行うことに興味を持つ多くの企業にとって、最高の投資目標に見合う国や、その国においてプロジェクトの必要条件に適合するサービス供給企業を決定することは、常に課題であります。
本レポートは、中国とインドにおける最も完全かつ包括的な比較を行いました。広範囲に及ぶ分野におけるこれら2国の類似点や相違点、医薬アウトソーシングにおけるこれらの国々の長所や短所、サービス能力の強みと欠点について、明らかにしました。さらに、革新的薬剤のR&D能力など、中国とインド間の製薬およびバイテク業界の詳細な比較も行いました。
また、個々の技術分野における市場規模やサービス能力など、個々の国における医薬アウトソーシング業界の現況について、深く理解することができます。さらに、個々の国をどのように適切に評価するか、また、開発目標やアウトソーシング戦略に最も適合する国をどのように決定するか、ということに関心を持つ製薬およびバイテク企業にとって、価値あるアドバイスを提供しています。
本レポートは、中国とインドのいずれかに関心を持つ製薬、バイテク、財政投資、およびアウトソーシングサービス業界におけるすべての専門家にとって、必読書であります。
目次
- Scope of the Report
- About Author
- Executive Summary
-
- China and India: The two most favored places for pharma outsourcing
- Advantages and disadvantages of China and India in pharma outsourcing: Head-to-head comparison of two countries
- Strengths and shortcomings of China and India in pharma outsourcing: Head-to-head comparison of top 50 best service providers of each country
- Which country best fits your outsourcing investment? - A series of case studies
- Chapter 1. China and India: The Two Most Favored Places for Pharma Outsourcing
-
Summary
1.1 Introduction1.1.1 World pharmaceutical industry is currently experiencing downturn and outsourcing is one of the effective solutions to quickly turn it around
1.1.2 Center of pharma outsourcing industry has shifted to the East
1.1.3 Emerging of China and India as favored places for outsourcing1. Emerging of Chinese pharma outsourcing industry1.2 Fast developpment patterns of pharma outsourcing industry in China and India
2. Emerging of Indian pharma outsourcing industry1.2.1 Development patterns of pharma outsourcing industry in China and India1. Development pattern of Chinese pharma outsourcing industry
2. Development pattern of Indian pharma outsourcing industry1.2.2 Market development of pharma outsourcing in China and India1. Market development of pharma outsourcing in Chinaa. Market development history and current market sizes of Chinese pharma outsourcing
b. Current market sizes of each service sector2. Market development of pharma outsourcing in Indiaa. Market development history and current market sizes of Indian pharma outsourcing
b. Current market sizes of each service sector3. How to compare with global pharma outsourcing marketsa. Current total market sizes of global pharma outsourcing industry1.3 Growing importance of China and India to world pharma industry
b. Current global market sizes of each service sector and their distributions
1.4 Summary of current development trend of global pharma outsourcing industry - Chapter 2. Advantages and Disadvantages of China and India in Pharma Outsourcing: Head-to-Head Comparison of Two Countries
-
Summary
2.1 Introduction
2.2 General comparisons between China and India2.2.1 Comparison of higher education systems between China and India2.3 Comparison of intellectual property (IP) protection environment between China and India
2.2.2 Comparison of workforce structure in pharmaceutical industry
2.2.3 Comparison of labor and raw material costs in pharmaceutical industry
2.2.4 Comparison of general industry infrastructure
2.2.5 Comparison of business philosophy
2.4 Comparison of pharmaceutical industries between China and India2.4.1 Comparison of development history of pharmaceutical industries in China and India
2.4.2 Comparison of pharmaceutical markets between China and India1. Chinese pharmaceutical market sizes
2. Indian pharmaceutical market sizes2.4.3 Comparison of general capabilities of pharmaceutical industry between China and India1. Chinese pharmaceutical industry
2. Indian pharmaceutical industry2.4.4 Comparison of drug R&D capabilities between China and India2.5 Comparison of biotech industries between China and India2.5.1 Chinese biotech industry2.6 Conclusions
2.5.2 Indian biotech industry - Chapter 3. Strengths and Shortcomings of China and India in Pharma Outsourcing: Head-to-Head Comparison of Top 50 Best Service Providers of Each Country
-
Summary
3.1 Introduction
3.2 Comparison of overall service capabilities of pharma outsourcing in China and India3.2.1 Overall service capability of Chinese pharma outsourcing industry3.3 Head-to-head comparison of top 50 best outsourcing service providers in each country
3.2.2 Overall service capability of Indian pharma outsourcing industry3.3.1 Selection of top 50 best service providers in each country
3.3.2 Criteria for selection of top 50 best service providers in each country1. Selection criteria
2. Classification and definition of CRO/CMO service capabilities
3. Classification of players and their ratings
4. Selection3.3.3 Head-to-head comparisons of selected top 50 best players in each country1. Comparison of service provider distributions3.4 Case studies: Head-to-head comparisons of typical Chinese companies with typical Indian companies
2. Comparison of professional service providers in each service sector
3. Comparison of service capabilities between Chinese companies and Indian companies
4. Comparison of current states of internal drug R&D programs and capabilities between Chinese companies and Ind an companies
5. Comparison of service capabilities in biopharmaceutical manufacturing
6. Comparison of global presences of Chinese companies and Indian companies
7. Summary of head-to-head comparisons3.4.1 Comparison between a Chinese CRO and an Indian CRO3.5 How financial crisis will affect the growths of pharma outsourcing industries in both countries: Comparison of future growth potentials of pharma outsourcing industries between China and India
3.4.2 Comparison between a major Chinese pharma company and a major Indian pharma company
3.4.3 Comparison between a major Chinese biotech company and a major Indian biotech company3.5.1 Future growth potential of pharma outsourcing in China1. Major short-term growth resistor: Financial crisis
2. Long term growth drivers and resistors1) Growth driversa. Internal drivers
b. External drivers
c. Three outsourcing waves2) Growth resistors: Challenges Chinese companies are going to face3.5.2 Future growth potential of pharma outsourcing in India1. Major short-term growth resistors: Impacts of terror attack and financial crisis
2. Long term growth drivers and resistors1) Growth drivers
2) Growth resistors - Chapter 4. Which Country Best Fits Your Outsourcing Investment? - A Series of Case Studies
-
Summary
4.1 Introduction
4.2 Analysis of real motivations behind different outsourcing strategies played by major pharma/biotech companies in China and India4.2.1 Different importance of China vs. India to major pharma/biotech companies for long term investment4.3 Case studies: Examples of drug companies around the world closely collaborating with Chinese and Indian companies
4.2.2 Different outsourcing strategies played in China and India by major pharma/biotech companies4.3.1 Collaboration between a major Western company and an Indian company4.4 Summaries of more outsourcing collaborations happened in recent two years between Western companies and Chinese or Indian companies
4.3.2 Collaboration between a major Western company and a Chinese company
4.3.3 Collaborations of a major Western company simultaneously with a Chinese company and an Indian company in similar therapeutic areas
4.5 Where to choose your outsourcing destination: In-depth analyses of pharma outsourcing features of both China and India - Classifications of Top 100 Best Outsourcing Service Providers in China and India
-
1. List of top pharma companies in China and India
2. List of top biotech companies in China and India
3. List of top CROs in China and India
4. List of top CMOs in China and India
5. List of top API and generic drug makers in China and India
6. List of Chinese and Indian companies with Level 5 service capability
7. List of Chinese and Indian companies with Level 4 service capability
8. List of Chinese and Indian companies with Level 3 service capability
9. List of top CROs in China and India for drug discovery service
10. List of top CROs in China and India for process R&D
11. List of top CROs in China and India for medicinal chemistry research
12. List of top CROs in China and India for preclinical research service
13. List of top CROs in China and India for ADME/Tox study
14. List of top CROs in China and India having non-human primate animal testing facilities
15. List of top CROs in China and India for clinical research service
16. List of top CROs in China and India having central lab service
17. List of top CROs in China and India in genomics and proteomics research
18. List of top Chinese and Indian pharma companies having internal R&D programs
19. List of top Chinese and Indian pharma companies having drug candidates in late development stages
20. List of top Chinese and Indian pharma companies having products marketed globally
21. List of top Chinese and Indian pharma companies having global presences - Appendix
-
Appendix I. Research Methodology
Appendix II. About JZMed, Inc. - List of Tables
-
Table 1. Comparison of labor costs in various locations of the world (FTE rates)
Table 2. Market distributions of each service sector in Chinese pharma outsourcing industry (2007 and 2008)
Table 3. Market development history of Indian pharma outsourcing industry
Table 4. Market distributions of each service sector in Indian pharma outsourcing industry (2006/2007 - 2007/2008)
Table 5. Market development of global pharma outsourcing industry in recent five years
Table 6. Market development history and future growth forecasts of each service sector of global pharma outsourcing industry (2006 to 2010)
Table 7. Comparison of higher education between China and India
Table 8. Comparison of technical workforces between China and India in pharma-related industries
Table 9. Comparison of labor and material costs in pharma outsourcing industries between China and India
Table 10. Current market sizes and future growth forecasts of Chinese pharmaceutical market
Table 11. Market development and future growth forecasts of Indian pharmaceutical markets
Table 12. Drug product development pipelines of Indian pharma and biotech companies
Table 13. Drug product development pipelines of Chinese pharma and biotech companies
Table 14. Head-to-head comparisons of advantages and disadvantages between China and India in pharma outsourcing-related industries
Table 15. Classification and definition of contract pharmaceutical research and manufacturing service capability levels
Table 16. List of top 50 best service providers in each country (In alphabetic order of company names)
Table 17. Comparison of distributions of service providers
Table 18. Comparison of professional service providers in each service sector
Table 19. Comparison of outsourcing service capabilities between Chinese companies and Indian companies
Table 20. Comparison of internal R&D programs between Chinese companies and Indian companies
Table 21. Comparison of companies providing service in biopharmaceutical manufacturing
Table 22. Comparison of global presences of Chinese companies and Indian companies
Table 23. Summary of latest acquisitions of Western companies by Indian companies
Table 24. Summary of comparisons between Chinese companies and Indian companies in pharma outsourcing-related industries
Table 25. Comparison of WuXi PharmaTech with GVK Biosciences
Table 26. Comparison of Harbin Pharmaceutical Group with Ranbaxy
Table 27. Comparison of Shanghai Sunway Biotech Co. with Intas Biopharmaceuticals Ltd.
Table 28. Comparison of predicted future outsourcing market developments between China and India (2009 and 2010)
Table 29. Head-to-head comparison of outsourcing collaborations of Ortho-McNeil Jassen Pharmaceuticals with a Chinese and an Indian company
Table 30. Summary of outsourcing collaborations happened recently between Western pharma/biotech companies and Chinese companies
Table 31. Summary of recent outsourcing collaborations between Western pharma/biotech companies and Indian companies
Table 32. Summary of Western CROs/CMOs establishing presences in China or forming partnerships with Chinese counterparts
Table 33. Summary of Western CROs/CMOs establishing presences in India or forming partnerships with Indian counterparts - List of Figures
-
Figure 1. Development history of Chinese pharma outsourcing market
Figure 2. Current market distributions of each service sector in Chinese pharma outsourcing industry (2008)
Figure 3. Market development history and future growth forecasts of India's CRAMS sector
Figure 4. Indian pharma outsourcing market growth history
Figure 5. Market growth history of Indian contract clinical research service sector
Figure 6. Current market distributions of each service sector of Indian pharma outsourcing industry (2007 ??2008)
Figure 7. Comparison between China and India of market shares of each service sector in each country's total pharma outsourcing markets (2008 data)
Figure 8. Global pharma outsourcing market: Growth history and future development forecasts
Figure 9. Market distributions of each service sector in global pharma outsourcing industry
Figure 10. Global contract research service: Market development, distributions and future growth forecasts of each sector (2006 ? 2010)
Figure 11. Chinese pharmaceutical market composition of 2008
Figure 12. Development history and future growth forecasts of Indian pharmaceutical market
Figure 13. Classification and rating of CROs and CMOs
Figure 14. Impacts of financial crisis on Chinese pharma outsourcing industry
Figure 15. Comparison of near future pharma outsourcing market sizes between China and India (2009 - 2010)
Figure 16. Comparison of future market growth potentials of Chinese and Indian pharma outsourcing industries (2010 ??2015)
Figure 17. Wholly-owned R&D centers established in China by major pharma and biotech companies
Figure 18. Major pharma and biotech companies having manufacturing facilities in China
Figure 19. Analysis of different investment strategies of major pharma and biotech companies in China and India
Figure 20. Summary of outsourcing models of major pharma and biotech companies in China and India
Figure 21. Comparisons of activities of Chinese companies and Indian companies in overseas markets
Figure 22. Examples of recent investment activities of Western VCs in China
Figure 23. Some typical shortcomings of China and India in pharma outsourcing
発刊日
2009/07/01
体裁
PDF / 152ページ
販売価格
1,499USD
発行
JZMed Inc
備考
※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。
関連カテゴリ
購入・お問い合わせ
